Activity measurements and determination of nuclear decay data of 166Ho in the MRTDosimetry project
- PMID: 31525708
- DOI: 10.1016/j.apradiso.2019.108826
Activity measurements and determination of nuclear decay data of 166Ho in the MRTDosimetry project
Abstract
Holmium-166 is a high-energy β--emitter radionuclide (~ 1.8 MeV) with a short half-life (~26.8h) that offers great potential as an alternative to 90Y for the treatment of liver cancer based on radioembolization. The possibility of quantitative Single Photon Emission Computed Tomography (SPECT) imaging of the main γ-ray emission at 80.6 keV, in addition to strong paramagnetic properties suitable for Magnetic Resonance Imaging (MRI), complement this therapeutic potential. The present paper describes the measurements carried out in three European radionuclide metrology laboratories for primary standardization of 166Ho and new determinations of X- and γ-ray photon-emission intensities in the framework of the European EMPIR project MRTDosimetry. New half-life measurements were also performed.
Keywords: Activity standardization; Half-life measurements; Ho-166; MRTDosimetry project; Molecular radiotherapy; γ-spectrometry.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization.Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e437-44. doi: 10.1016/j.ijrobp.2011.12.085. Int J Radiat Oncol Biol Phys. 2012. PMID: 22633554
-
Holmium-166 Radioembolization: Current Status and Future Prospective.Cardiovasc Intervent Radiol. 2022 Nov;45(11):1634-1645. doi: 10.1007/s00270-022-03187-y. Epub 2022 Jun 21. Cardiovasc Intervent Radiol. 2022. PMID: 35729423 Free PMC article. Review.
-
Quantitative Monte Carlo-based holmium-166 SPECT reconstruction.Med Phys. 2013 Nov;40(11):112502. doi: 10.1118/1.4823788. Med Phys. 2013. PMID: 24320461
-
MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation.Eur Radiol. 2013 Mar;23(3):827-35. doi: 10.1007/s00330-012-2648-2. Epub 2012 Sep 27. Eur Radiol. 2013. PMID: 23014797 Free PMC article. Clinical Trial.
-
[166Ho]-Loaded poly(L-lactic acid) microspheres.2010 Aug 19 [updated 2010 Oct 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Aug 19 [updated 2010 Oct 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20963939 Free Books & Documents. Review.
Cited by
-
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1268-1286. doi: 10.1007/s00259-024-06640-x. Epub 2024 Feb 17. Eur J Nucl Med Mol Imaging. 2024. PMID: 38366197 Free PMC article.
-
Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects.Cancers (Basel). 2022 Dec 22;15(1):68. doi: 10.3390/cancers15010068. Cancers (Basel). 2022. PMID: 36612062 Free PMC article.
-
Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs.Front Vet Sci. 2022 Nov 1;9:1015248. doi: 10.3389/fvets.2022.1015248. eCollection 2022. Front Vet Sci. 2022. PMID: 36387397 Free PMC article.
-
Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box.Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):18-29. doi: 10.1007/s00259-021-05583-x. Epub 2021 Nov 16. Eur J Nucl Med Mol Imaging. 2021. PMID: 34782911 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
